Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24-week, post-marketing SUNSHINE study

Published:2016-03-06 Issue:6 Volume:8 Page:809-815
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:J Diabetes

Author:

Gu Weiqiong¹,Liang Li.²,Wang Shengxiang³,Wang Yunzhi⁴,Wu Yanxiang⁵,Tian Jian⁶,Yang Gangyi⁷,Piao Chunli⁸,Li Yuzhong⁹,Yin Jianmei¹⁰,Xin Xiaoping¹¹,Tan Xingrong¹²,Ning Guang¹,Wang Weiqing¹,

Affiliation:

1. Ruijin Hospital; Shanghai

2. People's Hospital of Liaoning Province

3. Linyi People's Hospital; Linyi

4. The First Affiliated Hospital of Baotou Medical College; Baotou

5. Hospital 463 of PLA

6. Fengtian Hospital Affiliated to Shenyang Medical College; Shenyang

7. The Second Affiliated Hospital of Chongqing Medical University

8. The Affiliated Hospital to Changchun University of Chinese Medicine; Changchun

9. Dongguan Guanghua Hospital; Dongguan

10. Tianjin Third Hospital; Tianjin

11. Peking Union Medical College Hospital; Beijing China

12. Chongqing Ninth Hospital; Chongqing

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12360/fullpdf

Reference25 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;Diabetes Control and Complications Trial Research Group;New Engl J Med,1993

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study;Knowler;Lancet,2009

4. Treating type 2 diabetes: How safe are current therapeutic agents?;Philippe;Int J Clin Pract,2009

5. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone;DeFronzo;Diabetes Care,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Process Study on the Enzyme-Catalyzed Preparation of Key Chiral Intermediates for Saxagliptin;Pharmaceutical Fronts;2022-12

2. Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus;Journal of Diabetes Investigation;2020-03-27

3. Saxagliptin alters bile acid profiles and yields metabolic benefits in drug‐naïve overweight or obese type 2 diabetes patient;Journal of Diabetes;2019-07-29

4. Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial;Diabetes, Obesity and Metabolism;2017-12-18

5. Abnormal glucose regulation, hypoglycemic treatment during hospitalization and prognosis of acute ischemic stroke;Journal of the Neurological Sciences;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3